Age, sex, BMI, glycated hemoglobin (HbA1c), systolic blood pressure (SBP), and lipid levels were derived from trial data
How long does it take to notice the effects of retatrutide
What makes Retatrutide different from other peptides
We also express our appreciation to the Lonza Group, Basel, Switzerland, especially toward Miss Ulla Freitas for critically reading the manuscript and for supporting this research financially
The STEP clinical trial program, which evaluated higher doses of semaglutide (2.4 mg weekly) for chronic weight management, demonstrated significantly higher rates of vomiting, with approximately 20-25% of participants reporting this adverse effect during the study period